Safeguarding Global Health

Sentinel-Enabled Biosecurity Preparedness for a Safer Future

Avicena’s Biosecurity Preparedness solution enables nations and organisations to build resilient and scalable systems for rapid identification and containment of potential outbreaks.

A Continuing Need to Safeguard Our Lives & Economies

As the world becomes more interconnected, the risk of pandemics causing widespread devastation has never been higher.

The COVID-19 crisis revealed the inadequacy of global biosecurity infrastructure and the urgent need for more agile systems to meet new threats.

Recognising the importance of One Health for human and animal biosecurity preparedness, governments are now investing in creating advanced solutions for robust defences against future threats.

Avicena Sentinel Enables Biosecurity Preparedness

Avicena Sentinel is the world’s most scalable rapid molecular diagnostics platform, offering a daily surge capability of up to 100,000 tests.

The fully automated solution also offers flexible and on-demand sample loading, ensuring cost-effective testing for various volumes.

Sentinel’s comfortable saliva or nasal sample self-collection takes less than 20 seconds, and can be adapted for alternative sample matrices.

As a platform based on LAMP, a sensitive technology similar to PCR, Sentinel can readily adapt to existing tests for a wide variety of human and animal pathogens

Biosecurity Preparedness

Protecting Human Lives & Livelihoods

Human Biosecurity

Avicena’s Biosecurity Preparedness Solution enables nations and organisations to proactively prevent and control outbreaks through rapid early detection of infectious individuals at any scale.

Protecting Livestock & Food Security

Animal Biosecurity

Avicena Sentinel enables livestock and food industries to rapidly detect and monitor infectious diseases at any scale to safeguard animal health and food supply chains.

Flexible Biosecurity Platform

Sentinel ULTRA V3

Surge capacity up to 100,000 daily
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

Scientific Publications

Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance

Dewhurst RE, et al. 2022.Nature, Scientific Reports. Access here: DOI.

TGA Authorised¹

Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

CE-Marked Chemistry

CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.

Patent-Pending

Avicena holds several patent pending innovations that enable our groundbreaking performance.

¹Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.